Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPS-BOOSTER: Pneumococcal Vaccination in Inflammatory Rheumatic Disease
NCT03762824Phase 4Completed
- Sponsor
- Region Skåne
- Start
- Jun 2016
- Primary completion
- Sep 2018
- Modality
- Split/Subunit Vaccines
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease, sponsored by Region Skåne. Started Jun 2016; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT03762824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762824.